Progressive changes from idiopathic macular telangiectasia seen with spectral domain optical coherence tomography.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie

• Publication date

  2010-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3129/i10-038PMID 20648067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BEVACIZUMAB (AVASTIN) THERAPY FOR IDIOPATHIC MACULAR TELANGIECTASIA TYPE II

  2009cited by this paper
• Early morphological changes and functional abnormalities in group 2A idiopathic juxtafoveolar retinal telangiectasis using spectral domain optical coherence tomography and microperimetry

  2008cited by this paper
• Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.

  2007cited by this paper
• Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography.

  2006cited by this paper
• Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology.

  2005cited by this paper

• Retinal cavitations in macular telangiectasia type 2 (MacTel): longitudinal structure–function correlations

  2020cites this paper
• Multimodality imaging in macular telangiectasia 2: A clue to its pathogenesis

  2015cites this paper
• When is macular edema not macular edema? An update on macular telangiectasia type 2☆

  2015cites this paper
• Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2).

  2013cites this paper
• [Idiopathic macular telangiectasia: clinical appearance, imaging and treatment].

  2013cites this paper